About the Moon Shots Program

Our Model

The Moon Shots Program® tackles cancer in three ways:
innovation, scale and collaboration. These are methods which work
stronger together. MD Anderson has one of the largest patient bases
and uses 10 research platforms to find patterns, evaluate treatments
and predict outcomes. We work for results — preventive education,
first-of-a-kind clinical trials and personalized surgeries are just a
few. Finally, the Moon Shots Program brings experts together in
exciting and effective ways. When we invite participation and apply
interdisciplinary learnings and tools, we get even closer to ending cancer.

INNOVATION

We've changed the game with our fresh approach to organizing our resources to end cancer. Through this novel organizational paradigm, we are going beyond discovery, leading to new drugs, new ways to prevent cancer and new ways of sharing knowledge.

SCALE

We have more than 21,000 employees focused on one mission: to end cancer. Each year we treat more than 100,000 people, and we have more than 1,200 clinical trials open that yield significant results and extend our ability to execute. With our critical mass and global reach, we are poised to make an enormous impact on the lives of cancer patients and their families.

COLLABORATION

We believe in the power of collective, interdisciplinary thinking. That’s why we’ve pooled our resources to attack cancer as a unified force. This team-science mentality accelerates research efforts by taking a more agile approach to leveraging the right resources and infrastructure. Our strategic business alliances, Cancer Network and Sister Institution Network help us make a global impact.

1 of 1

Our people

Giulio Draetta, M.D., Ph.D., is co-leader of the Moon Shots Program®. Learn more about his research, why he joined MD Anderson and how he thinks the program is making a difference.